
Medical Device and Pharmaceutical R&D Manufacturer



Jiang Huixia, founder and chairman of Shell Society, said,In the AI era, knowledge is becoming increasingly inexpensive. When the authorities at the top of the pyramid are no longer mysterious, and when standard answers become easier to find, we need to collaboratively explore learning in the AI era.More importantly, there needs to be face-to-face, in-person exchange of ideas, inspiring each other.In a pile of homogeneous involution,Explore the unique value of individuals and enterprises, and seek and break through development paths.Improve management level.
This course adopts a "systematic teaching + private board meeting" dual-track parallel model. Authoritative experts in the industry not only systematically explained cutting-edge product strategy frameworks and efficient project management practices, but also, through senior private board coaching and real-scenario drills, comprehensively enhanced the core capabilities of participants in corporate strategic planning, execution, and dynamic decision-making from early R&D to successful commercialization.






AsFounder and Chairman of Shell Society Jiang HuixiaAt the Cooperation and Exchange Meeting of Shanghai Medical Engineering Transformation and Science Innovation Talent Platform on the afternoon of May 16, it was emphasized that Shell Society has independently created and implemented a "four-in-one" full-chain service system of "education empowerment + professional guidance + resource connection + capital acceleration." Relying on the systematic entrepreneurial courses of Shell Academy, in-depth coaching by an elite mentor team, and precise investment from Shell Fund in "early-stage, small-scale, and hard technology" projects, the potential of entrepreneurs is tapped, the success rate of entrepreneurship is enhanced, and new forces with global influence in China's medical and health fields are nurtured.
Facing the current critical opportunity period for going global, BioClub is also actively making strategic moves to build an innovation and entrepreneurship ecosystem that spans from local incubation to global expansion. It is actively establishing service networks in Australia, Hong Kong, Singapore, and other places, connecting Chinese entrepreneurs with top overseas clinical resources, registration certifications, and commercial market channels, while also assisting in introducing high-quality overseas projects into China.
BioClub supports Chinese healthcare entrepreneurs in achieving a value leap from technological breakthroughs to global market expansion by providing gradient services that cover the entire lifecycle of enterprises. These services range from initial team building and enterprise lifecycle management to industrial collaboration, commercial promotion, and subsequent financing and IPO planning.
